Consistent with these mechanistic insights, early clinical reports suggested up to a four-fold increase in breast cancer risk among women with acromegaly and more recent studies have demonstrated a positive association between cumulative GH/IGF-1 exposure and breast cancer incidence (18, 37, 38). Here, GH1 is linked to acromegaly.